Medicare Enrolled
Dr. Hernan Baquerizo, M.D.
Endocrinology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baquerizo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baquerizo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baquerizo
Dr. Hernan Baquerizo is an endocrinology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Baquerizo performed 1,492 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Baquerizo received a total of $18,222 from 45 pharmaceutical and/or device companies across 903 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baquerizo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 34% volume in FL
$18,222 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 41627 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗1,492
Medicare services
Top 34% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
465 | $96 | $275 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
415 | $3 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
125 | $144 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
90 | $104 | $225 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $69 | $300 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
74 | $91 | $280 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $151 | $430 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
62 | $29 | $132 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
45 | $10 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $134 | $375 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $74 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $114 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$18,222
Total received (2018-2024)
Avg $2,603/year across 7 years
Top 19% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
903
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,666
2023
$2,241
2022
$2,720
2021
$3,200
2020
$2,661
2019
$2,942
2018
$2,792
Payments by company (2024)
Lilly USA, LLC
$324
Novo Nordisk Inc
$248
Mannkind Corporation
$192
Amneal Pharmaceuticals LLC
$118
SANOFI-AVENTIS U.S. LLC
$95
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Dexcom, Inc.
$84
CeQur Corporation
$84
Corcept Therapeutics
$83
ABBVIE INC.
$67
Abbott Laboratories
$63
Esperion Therapeutics, Inc.
$38
Amgen Inc.
$35
Kyowa Kirin, Inc.
$27
Novartis Pharmaceuticals Corporation
$26
Radius Health, Inc.
$25
Xeris Pharmaceuticals, Inc.
$23
Tandem Diabetes Care, Inc.
$23
Insulet Corporation
$23
Top 3 companies account for 45.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$2,519
AstraZeneca Pharmaceuticals LP
$2,444
SANOFI-AVENTIS U.S. LLC
$1,949
Novo Nordisk Inc
$1,353
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,243
Mannkind Corporation
$1,076
MannKind Corporation
$962
Amneal Pharmaceuticals LLC
$929
Abbott Laboratories
$568
AbbVie Inc.
$412
Shire North American Group Inc
$342
Merck Sharp & Dohme Corporation
$331
Xeris Pharmaceuticals, Inc.
$298
Janssen Pharmaceuticals, Inc
$279
AbbVie, Inc.
$271
Amgen Inc.
$266
Radius Health, Inc.
$255
CeQur Corporation
$252
Tandem Diabetes Care, Inc.
$250
Insulet Corporation
$247
Zealand Pharma US, Inc.
$225
Dexcom, Inc.
$225
Esperion Therapeutics, Inc.
$173
Gemini Laboratories, LLC
$152
Amarin Pharma Inc.
$123
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$118
Medtronic, Inc.
$117
Corcept Therapeutics
$106
ABBVIE INC.
$93
Horizon Therapeutics plc
$90
DEXCOM, INC.
$67
Merck Sharp & Dohme LLC
$63
LIFESCAN, INC.
$59
Novartis Pharmaceuticals Corporation
$49
LifeScan, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$44
IBSA Pharma Inc.
$36
Senseonics, Incorporated
$36
Kyowa Kirin, Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$23
Ultragenyx Pharmaceutical Inc.
$22
Antares Pharma, Inc.
$22
Medtronic MiniMed, Inc.
$20
Clarus Therapeutics Inc.
$20
Currax Pharmaceuticals LLC
$16
Top 3 companies account for 37.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BYDUREON · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUMET · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · MINIMED 780G · MOUNJARO · MULTAQ · Minimed Paradigm Revel · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OT Verio Flex Starter Kit · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNJARDY · SYNTHROID · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · XARELTO · XIGDUO · XYOSTED · ZEGALOGUE · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
114
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Baquerizo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Baquerizo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Baquerizo performed 465 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Baquerizo receive payments from pharmaceutical companies?
Yes. Dr. Baquerizo received a total of $18,222 from 45 companies across 903 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baquerizo's costs compare to other endocrinologists in Miami?
Dr. Baquerizo's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baquerizo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Miami
Browse endocrinologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology